The androgen receptor downregulation reduced GC cell migration, invasion, and suppressed EMT-related pathways [34].In comparison to primary tumors, the androgen receptor and TGFβ pathway transcripts were elevated in patient-derived xenografts (PDXs) and circulating tumor cells (CTCs) from triple-negative breast cancer patients [35]. The gene discussed is TGFB1; the disease is triple-negative breast carcinoma.